These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1448792)

  • 1. Markers of coagulation activation in inherited protein S deficiency.
    Leroy-Matheron C; Lamare M; Levent M; Gouault-Heilmann M
    Thromb Res; 1992 Sep; 67(5):607-12. PubMed ID: 1448792
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombophilia and complex acquired deficiencies of antithrombin, protein C, and protein S.
    Humphries JE
    Semin Hematol; 1995 Oct; 32(4 Suppl 2):8-16; discussion 17-8. PubMed ID: 8821205
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasmatic markers of haemostatic system activation in patients with solid neoplasms.
    Sagripanti A; Carpi A; Ferdeghini M; Baicchi U; Grassi B
    J Nucl Med Allied Sci; 1990; 34(4):321-32. PubMed ID: 2151044
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of conditions of blood sampling on coagulation activation markers (prothrombin fragment 1 + 2, thrombin-antithrombin complexes and D-dimers) measurements.
    Leroy-Matheron C; Gouault-Heilmann M
    Thromb Res; 1994 May; 74(4):399-407. PubMed ID: 8085241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombin III supplementation during orthotopic liver transplantation in cirrhotic patients: a randomized trial.
    Baudo F; DeGasperi A; deCataldo F; Caimi TM; Cattaneo D; Redaelli R; Pannacciulli E; Corti A; Mazza E; Belli L
    Thromb Res; 1992 Dec; 68(4-5):409-16. PubMed ID: 1290169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen.
    Boisclair MD; Lane DA; Wilde JT; Ireland H; Preston FE; Ofosu FA
    Br J Haematol; 1990 Apr; 74(4):471-9. PubMed ID: 2189490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinolysis, antithrombin III, and protein C in neonates during cardiac operations.
    Petăjă J; Peltola K; Sairanen H; Leijala M; Kekomäki R; Vahtera E; Siimes MA
    J Thorac Cardiovasc Surg; 1996 Sep; 112(3):665-71. PubMed ID: 8800154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulopathy in hemorrhagic fever with renal syndrome (Korean hemorrhagic fever).
    Lee M; Kim BK; Kim S; Park S; Han JS; Kim ST; Lee JS
    Rev Infect Dis; 1989; 11 Suppl 4():S877-83. PubMed ID: 2568677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fibrinogen degradation products, soluble fibrin and antithrombin III in toxic goiter patients].
    Panchenko VM; Salakhidinov Z; Khaĭkina MB
    Probl Endokrinol (Mosk); 1979; 25(1):11-5. PubMed ID: 581702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coagulation profile and the ethanol gelation test with special reference to components consumed during coagulation.
    Slaastad RA; Godal HC
    Scand J Haematol; 1976 Jan; 16(1):25-32. PubMed ID: 1251137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombin III replacement in orthotopic liver transplantation.
    Coccheri S; Palareti G
    Semin Thromb Hemost; 1993; 19(3):268-72. PubMed ID: 8362256
    [No Abstract]   [Full Text] [Related]  

  • 12. Fibrin monomer complexes (SFMC) after substitution of antithrombin III (AT III) in consumption coagulopathy.
    Töpfer G; Ehrhardt W; Dornheim G; Seifert A; Schmidt LH; Senger C; Funke U; Schulze M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):581-5. PubMed ID: 2465977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock.
    Gando S; Nanzaki S; Sasaki S; Aoi K; Kemmotsu O
    Crit Care Med; 1998 Dec; 26(12):2005-9. PubMed ID: 9875912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Does D-dimer help when blood coagulates?].
    Lassila R
    Duodecim; 1999; 115(24):2707-9. PubMed ID: 11979609
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hemocoagulation disorders in patients with acute pancreatitis].
    Dronov OI; Koval's'ka IO; Burmich KS; Tsymbaliuk RS; Uvarov VIu; Lubenets' TV
    Lik Sprava; 2010; (7-8):38-44. PubMed ID: 21714285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relative frequency of inherited inhibitor deficiency among 93 young patients with thrombophilia in Algeria.
    Chafa O; Fischer AM; Sternberg C; Meriane F; Millien C; Benabadji M
    Blood Coagul Fibrinolysis; 1993 Aug; 4(4):639-40. PubMed ID: 8218863
    [No Abstract]   [Full Text] [Related]  

  • 17. Level of antithrombin III, protein C, protein S and other selected parameters of coagulation and fibrinolysis in the blood of the patients with recurrent deep venous thrombosis.
    Swiatkiewicz A; Jurkowski P; Kotschy M; Ciecierski M; Jawień A
    Med Sci Monit; 2002 Apr; 8(4):CR263-8. PubMed ID: 11951068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of coagulation disorders in patients with acute leukemia before and after cytostatic treatment.
    Chojnowski K; Wawrzyniak E; Treliński J; Niewiarowska J; Cierniewski C
    Leuk Lymphoma; 1999 Dec; 36(1-2):77-84. PubMed ID: 10613452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homozygous type I plasminogen deficiency.
    Mingers AM; Heimburger N; Zeitler P; Kreth HW; Schuster V
    Semin Thromb Hemost; 1997; 23(3):259-69. PubMed ID: 9255907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Deficiencies of physiological coagulation inhibitors in children with venous thromboses of the lower limbs. Prospective study of 6 cases].
    Khaldi F; Toumi NH; Ben Jaballah N; Zriba S; Ben Naceur B
    Ann Pediatr (Paris); 1993 Jun; 40(6):348-52. PubMed ID: 8352495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.